S H Kelkar and Company Limited has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2025 -Financial Results.
SHK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 12.3 pts more than Nifty Microcap 250 and 12.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
S H Kelkar's board approved audited consolidated results for Q4 and FY ended March 31, 2025. Consolidated revenue from operations rose to Rs 2,123.40 crores from Rs 1,840.83 crores in FY24 (about 15% growth), but profit for the year fell sharply to Rs 73.01 crores from Rs 123.55 crores in FY24, mainly due to an exceptional loss of Rs 65.36 crores linked to the April 2024 Vashivali plant fire (gross asset/inventory loss of Rs 160.18 crores, partly offset by Rs 95 crore approved insurance claim, of which Rs 87.72 crore was received post year-end). Q4 standalone PAT turned into a net loss for the year, though consolidated Q4 PAT jumped to Rs 102.51 crores from Rs 33.43 crores. The board recommended a final dividend of Re. 1 per share (10%) for FY25, subject to AGM approval on August 12, 2025. The company also approved a new wholly-owned subsidiary Keva Middle East FZE in the UAE and made director/auditor appointments. Statutory auditor Deloitte Haskins & Sells LLP issued an unmodified opinion on both standalone and consolidated results.
Top-line growth is encouraging, but the fire-related exceptional charge and higher operating costs have compressed full-year profits by roughly 41%. The pending insurance recoveries (balance ~Rs 7 crore) and UAE subsidiary expansion could be positive triggers in FY26. The 10% dividend signals continued cash returns to shareholders despite a tough year.